Elevra Lithium shares (ASX: ELV) fell 4.04% to close yesterday’s session at A$4.99, pushing the company’s market cap below the A$1 billion level to A$965.92 million. A landmark spodumene supply agreement with battery heavyweight LG Energy Solution failed to arrest the sell-off in Elevra Lithium shares, which now sit 63.06% lower in the past five months.

The stock’s RSI has also fallen to 23.56 on the day, placing ELV firmly among the most technically oversold names on the entire ASX. If the market cap had not slipped below A$1b, the stock would be the most oversold name of its size, the unwanted crown instead going to GDG.

Offtake Agreement Keeps ELV Exposed To Spot Prices

Despite the negative price action, Thursday’s headline announcement represented a genuine commercial milestone for Elevra. The company confirmed a binding, three-year spodumene concentrate offtake agreement with LG Energy Solution (LGES), one of the world’s largest lithium-ion battery manufacturers, covering production from its operational North American Lithium (NAL) project in Québec, Canada.

Under the terms of the deal, Elevra will supply a base volume of 240,000 dry metric tonnes (dmt) of spodumene concentrate across the contract period. Deliveries are structured to ramp progressively from first shipment, with 30,000 dmt scheduled for 2026, rising to 60,000 dmt in each of 2027 and 2028, and reaching 90,000 dmt in 2029. An additional optional tranche of up to 90,000 dmt is available subject to mutual agreement between both parties, providing a potential upside volume lever if market conditions improve.

Pricing under the agreement is market-linked and adjusted for lithium content, meaning Elevra retains full exposure to prevailing spodumene spot prices rather than locking in a fixed floor.

 

Top Australian Brokers

That structure is a double-edged arrangement, as it preserves the company’s ability to capture upside if lithium prices recover, but it equally offers no revenue protection during periods of commodity weakness, like the environment markets are navigating today.

Chief Executive Officer Lucas Dow described the agreement as a meaningful step in the company’s commercial development.

“This agreement gives Elevra a committed customer for a meaningful portion of NAL’s production as we progress the NAL expansion,” Dow said, framing the deal as central to the company’s FY26 commercial strategy of securing tier-one partnerships while maintaining commodity price optionality.

The Next Leg

Securing a tier-one battery manufacturer as a cornerstone customer validates both the quality of NAL’s spodumene concentrate and Elevra’s operational credibility as a supplier.

However, the market-linked pricing mechanism is the critical caveat that tempers the immediate commercial impact of the announcement. Spodumene concentrate prices have declined sharply from their 2022 peaks and have yet to demonstrate a sustained floor.

From a technical standpoint, an RSI of 23.56 places ELV in territory where short-covering rallies are historically more probable, particularly if broader lithium sector sentiment shifts on any positive macro catalyst. That said, technically oversold conditions are more than capable of remaining depressed for quarters at a time when the macro remains against the stock.

Elevra Lithium shares head into the final trading session of the week under pressure, yet armed with an agreement that anchors a meaningful portion of NAL’s future production. It is a good start, yet there remains a long way back if bulls are to shift momentum, starting with the macro backdrop that is outside of it’s control.

Bull Case:

  • Tier-1 offtake partner LGES secured, validating NAL product quality and commercial credibility
  • Market-linked pricing preserves full upside exposure if spodumene spot prices recover
  • RSI of 23.56 signals deep technical oversold conditions, raising mean-reversion probability

Bear Case:

  • Market-linked contract provides zero revenue floor protection in a depressed lithium market
  • Loss of A$1 billion market cap risks index exclusion and reduced institutional mandate eligibility
  • Five-month, 63% share price decline reflects persistent sector outflows overwhelming positive news
The Bull Team
The Bull Team is a group of finance writers and journalists that provide commentary and insights on the Australian stock market and beyond.